登入
選單
返回
Google圖書搜尋
Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy-acetyl)-L-alanyl-D-glutamic acid (LK-423)
Marija Bogataj
Aleš Mrhar
Anton Lavrič
Manica Černe
Doris Tibaut
Anton Štalc
Uroš Urleb
Tatjana Mateović
Greta Cof
Janez Kerč
Rok Dreu
Fumio Yomeda
其他書名
patentna prijava št.: WO 2005092295 A1
出版
2005
URL
http://books.google.com.hk/books?id=-VaVOgAACAAJ&hl=&source=gbs_api
註釋
The present invention relates to the pharmaceutical dosage forms which enabled a controlled and/or a targeted drug delivery of an active substance tothe selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2phthalimidoethoxy-acetyl)-L-alanyl-D-glutamic acid (designed as LK-423).Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed.
